(Adnkronos Health) – “The first version of the Table includes an advanced search engine with dynamic filters and an interactive graphical visualization – adds Malapelle -. With these two tools, it will be possible to manage variants and their classifications, but subsequently, the platform will be developed with a modular architecture. It will be prepared for integration with scientific databases and external sources. Shared and standardized criteria will be adopted for ever-improving classification of variants and adequate support for clinical practice.”
“In general, in the era of precision medicine, collaboration with molecular pathologists is crucial for the oncology community – concludes Di Maio -. The quality and timeliness of diagnostics are essential for the optimal management of our patients. The evolution of the diagnostic and therapeutic scenario that underpins the platform we are presenting today reminds us how important, on these topics, is the commitment of Scientific Societies on various fronts: updating and training operators, the availability of useful tools to improve and standardize the appropriateness of clinical decisions, interaction with institutions to promote the optimal and timely implementation of innovations in clinical practice, counteracting the risks of disparities in access to the best diagnostics and therapies. In a national congress for which we chose the slogan ‘Equitable Innovation’, I believe reiterating these points is very important.”